| Old Dog, New Trick: Type I IFN–Based Treatment for Acute Myeloid Leukemia A Alsufyani, R Alanazi, JF Woolley, LN Dahal Molecular Cancer Research 19 (5), 753-756, 2021 | 4 | 2021 |
| Nuclear factor IC overexpression promotes monocytic development and cell survival in acute myeloid leukemia N Rastogi, JBM Gonzalez, VK Srivastava, B Alanazi, RN Alanazi, ... Leukemia 37 (2), 276-287, 2023 | 2 | 2023 |
| S100A4 Expression Protects AML Cells from V-Atpase Mediated Apoptosis Via the Nuclear Receptor Coactivator, NCOA7 RNS Alanazi, S Rizzo, A Gilkes, S Knapper, RL Darley, A Tonks Blood 144, 6129, 2024 | | 2024 |
| Risk Factors and Prognosis of Chronic Myeloid Leukemia in Saudi Arabia: A Systematic Review SZN Alanazi, RNS Alanazi, MN Alanazi Asian Journal of Medicine and Health 22 (1), 13-20, 2024 | | 2024 |
